Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-01-05 @ 1:39 PM
Study NCT ID:
NCT00978432
Status:
TERMINATED
Last Update Posted:
2016-11-25
First Post:
2009-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor:
Anne Beaven, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-15
First Submit QC Date:
None
Study First Post Date:
2009-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-17
Results First Submit QC Date:
None
Results First Post Date:
2016-06-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-12
Last Update Post Date:
2016-11-25
Last Update Post Date Type:
ESTIMATED